Combined Effect of Low-Density Lipoprotein Cholesterol and Homocysteine on Major Adverse Cardiovascular Events in Coronary Heart Disease: A Retrospective Cohort Study

Read full text Summarise with VIRAT
Authors: Baozhen Zhu, Xingyu Luo, Peng Wu, Yuru Ma, Bo Wu, Ru Yan, Tianshui Ma, Jian Yang, Ziyi Wang, Guangzhi Cong, Shaobin Jia
Cited by: 0
References: 32

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Residual cardiovascular risk remains substantial despite aggressive low-density lipoprotein cholesterol (LDL-C) lowering in coronary heart disease (CHD). Consequently, this elevated risk has spurred the search for non-lipid targets, such as homocysteine (HCY). However, the combined effect of HCY with LDL-C and the overall potential for combined risk stratification remain unclear. Methods: This retrospective cohort study included patients with CHD confirmed by coronary angiography or computed tomography angiography at the General Hospital of Ningxia Medical University between January 2019 and December 2021. Participants were stratified by baseline LDL-C levels (

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Folate and B Vitamins Research Diabetes Cardiovascular Risks and Lipoproteins

Publication details

Journal / source
Reviews in Cardiovascular Medicine
Volume
27
Issue
3
Pages
46290–46290
Publication date
16 March 2026
Language
EN